Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary
- PMID: 28543974
- DOI: 10.1002/jum.14260
Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary
Abstract
Objectives: Follow-up of patients with low-risk differentiated thyroid cancer treated with total thyroidectomy and radioiodine requires neck sonography and thyroglobulin (Tg). The need to stimulate Tg is controversial. The goal of this study was to compare the diagnostic performances of sonography plus suppressed or stimulated Tg in low-risk thyroid cancer.
Methods: After total thyroidectomy and radioiodine, patients with low-risk thyroid cancer were retrospectively identified as having structural or biochemical persistence/recurrence. We compared the diagnostic performance of suppressed and stimulated Tg to detect persistence/recurrence.
Results: We included 148 patients with low-risk thyroid cancer who were followed for a median of 3.7 years. Persistence/recurrence was found in 8 patients (5.4%; 5 structural disease and 3 biochemical disease). Thyroglobulin was not stimulated in 72 patients (group 1) and stimulated in 76 (group 2). In group 1, 5 patients (6.9%) had structural neck persistence/recurrence (3 with suppressed Tg ≥ 1 ng/mL and 2 with suppressed Tg < 1 ng/mL). Four patients underwent surgery, and 1 was surveilled. All 5 patients had suppressed Tg lower than 1 ng/mL at the end of follow-up. In group 2, stimulated Tg did not identify additional cases of structural persistence/recurrence but classified 3 patients (3.9%) as having biochemical persistence/recurrence. One patient received a second dose of radioiodine, and the other 2 were surveilled; all were without disease at the end of follow-up. Suppressed and stimulated Tg had negative predictive values for persistence/recurrence of 97% and 100%, respectively.
Conclusions: In low-risk thyroid cancer treated with total thyroidectomy and radioiodine, sonography and suppressed or stimulated Tg have similar negative predictive values for persistence/recurrence. Importantly, the coexistence of negative sonographic findings and suppressed Tg lower than 1 ng/mL makes the addition of stimulated Tg unlikely to identify clinically important disease.
Keywords: adult thyroid; clinical; general; head and neck ultrasound; radiation treatment; radiology; surgery; thyroid cancer.
© 2017 by the American Institute of Ultrasound in Medicine.
Similar articles
-
Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.J Ultrasound Med. 2018 Oct;37(10):2325-2331. doi: 10.1002/jum.14580. Epub 2018 Mar 2. J Ultrasound Med. 2018. PMID: 29498418
-
Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation.Thyroid. 2017 Apr;27(4):531-536. doi: 10.1089/thy.2016.0479. Epub 2017 Jan 23. Thyroid. 2017. PMID: 28007013
-
Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.Asian Pac J Cancer Prev. 2014;15(6):2523-7. doi: 10.7314/apjcp.2014.15.6.2523. Asian Pac J Cancer Prev. 2014. PMID: 24761858
-
Follow-up of differentiated thyroid carcinoma.Minerva Endocrinol. 2004 Dec;29(4):161-74. Minerva Endocrinol. 2004. PMID: 15765026 Review. English, Italian.
-
Papillary thyroid cancer: medical management and follow-up.Curr Treat Options Oncol. 2005 Jul;6(4):323-38. doi: 10.1007/s11864-005-0036-8. Curr Treat Options Oncol. 2005. PMID: 15967085 Review.
Cited by
-
Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend.J Endocrinol Invest. 2019 Oct;42(10):1223-1230. doi: 10.1007/s40618-019-01044-3. Epub 2019 Apr 8. J Endocrinol Invest. 2019. PMID: 30963467
-
Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936-2015).World J Surg. 2018 Feb;42(2):329-342. doi: 10.1007/s00268-017-4279-x. World J Surg. 2018. PMID: 29030676
-
The Prognostic Role of Postablative Non-Stimulated Thyroglobulin in Differentiated Thyroid Cancer.Cancers (Basel). 2021 Jan 15;13(2):310. doi: 10.3390/cancers13020310. Cancers (Basel). 2021. PMID: 33467717 Free PMC article.
-
The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer.Front Endocrinol (Lausanne). 2022 Jun 2;13:872527. doi: 10.3389/fendo.2022.872527. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35721746 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous